Reference health

pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer

https://doi.org/10.1186/s12951-021-00895-4
CiteStamped reference-health badge
2 of 39 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

References needing attention

marked retracted by the publisher10.1038/s41467-018-02915-8
RETRACTED ARTICLE: Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
marked retracted by the publisher10.1038/s41467-020-20588-0
RETRACTED ARTICLE: Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance
The 37 checked references that resolve
resolves10.21037/tlcr.2018.05.06
The epidemiology of lung cancer
resolves10.1016/j.cllc.2016.05.003
Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America
resolves10.1016/j.ajps.2018.06.006
Triphenylphosphonium-modified mitochondria-targeted paclitaxel nanocrystals for overcoming multidrug resistance
resolves10.1016/j.phrs.2015.03.007
The multifaceted mitochondrion: An attractive candidate for therapeutic strategies
resolves10.1016/j.biochi.2019.12.002
Deletion of CDR1 reveals redox regulation of pleiotropic drug resistance in Candida glabrata
resolves10.1016/j.yexcr.2018.10.013
MicroRNA-98 promotes drug resistance and regulates mitochondrial dynamics by targeting LASS2 in bladder cancer cells
resolves10.1021/acsami.6b06522
Mitochondria-Targeted Chimeric Peptide for Trinitarian Overcoming of Drug Resistance
resolves10.18632/aging.103336
First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds
resolves10.1111/jcmm.13485
LysoTracker and MitoTracker Red are transport substrates of P‐glycoprotein: implications for anticancer drug design evading multidrug resistance
resolves10.1007/978-981-10-6674-0_11
Metabolic Regulation in Mitochondria and Drug Resistance
resolves10.18632/oncotarget.2789
Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition
resolves10.1016/j.bj.2019.04.003
Topological properties and in vitro identification of essential nodes of the Paclitaxel and Vincristine interactomes in PC-3 cells
resolves10.1016/j.ccell.2015.05.009
Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules
resolves10.1016/j.talanta.2020.121127
A TAT peptide-based ratiometric two-photon fluorescent probe for detecting biothiols and sequentially distinguishing GSH in mitochondria
resolves10.1021/ja044006q
Highly Efficient, Nonpeptidic Oligoguanidinium Vectors that Selectively Internalize into Mitochondria
resolves10.1039/C9MD00572B
TPP-based mitocans: a potent strategy for anticancer drug design
resolves10.1186/s12951-019-0562-3
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
resolves10.1016/j.biomaterials.2014.05.063
Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer
resolves10.1016/j.biomaterials.2012.08.007
Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer
resolves10.1016/j.biomaterials.2013.08.032
Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers
resolves10.1021/ja207150n
Tailor-Made Dual pH-Sensitive Polymer–Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery
resolves10.1016/j.jconrel.2020.03.011
Stepwise dual targeting and dual responsive polymer micelles for mitochondrion therapy
resolves10.1016/S0142-9612(03)00207-2
Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system
resolves10.1016/j.biomaterials.2013.01.078
The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer
resolves10.1016/j.biomaterials.2011.01.038
The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery
resolves10.2174/1871520619666190725122400
Jab1-siRNA Induces Cell Growth Inhibition and Cell Cycle Arrest in Gall Bladder Cancer Cells via Targeting Jab1 Signalosome
resolves10.7150/thno.33353
Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms
resolves10.1016/j.bcp.2017.03.007
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways
resolves10.5114/aoms.2019.89979
Inhibition of miR-22 promotes differentiation of osteoblasts and improves bone formation via the YWHAZ pathway in experimental mice
resolves10.3892/ol.2020.12327
Effects of matrine in combination with cisplatin on liver cancer
resolves10.3390/nano8121034
Self-Assembled Triphenylphosphonium-Conjugated Dicyanostilbene Nanoparticles and Their Fluorescence Probes for Reactive Oxygen Species
resolves10.1002/smll.202001747
ATP Suppression by pH‐Activated Mitochondria‐Targeted Delivery of Nitric Oxide Nanoplatform for Drug Resistance Reversal and Metastasis Inhibition
resolves10.1021/acsami.6b00263
Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer
resolves10.1016/j.colsurfb.2015.01.039
Thiol-responsive gemini poly(ethylene glycol)-poly(lactide) with a cystine disulfide spacer as an intracellular drug delivery nanocarrier
resolves10.2147/IJN.S281649
<p>Mitochondria-Targeting Oxygen-Sufficient Perfluorocarbon Nanoparticles for Imaging-Guided Tumor Phototherapy</p>
resolves10.1002/ijc.32521
Melanoma‐derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment
resolves10.1016/j.semcancer.2019.07.016
Metabolic flexibility in melanoma: A potential therapeutic target
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1186/s12951-021-00895-4"><img src="https://citestamp.com/citestamped/10.1186/s12951-021-00895-4/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1186/s12951-021-00895-4/badge.svg)](https://citestamp.com/citestamped/10.1186/s12951-021-00895-4)